Comparative study between intact PTH and fragments of PTH in patients on hemodialysis and CAPD

M Martinez1, M Ausejo, J L Miguel

  • 1Biochemistry and Nephrology Service, Hospital La Paz Madrid, Spain.

Insights

Continuous ambulatory peritoneal dialysis (CAPD) may alter parathyroid hormone (PTH) levels, specifically mid-molecule PTH (MM-PTH), due to peritoneal losses. Hemodialysis (HD) patients showed higher MM-PTH than CAPD patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biochemistry

Background:

  • Secondary hyperparathyroidism is common in patients with chronic kidney disease.
  • Different dialysis modalities may impact parathyroid hormone (PTH) metabolism and clearance.
  • Understanding PTH fragment levels is crucial for managing mineral and bone disorders in dialysis patients.

Purpose of the Study:

  • To compare serum parathyroid hormone (PTH) levels, including mid-molecule (MM-PTH) and intact PTH (Intact PTH), between patients on hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD).
  • To investigate the relationship between different PTH fragments and dialysis modality.
  • To assess the potential impact of peritoneal losses on PTH levels in CAPD patients.

Main Methods:

  • Serum calcium, phosphorous, and PTH levels were measured in 29 HD and 29 CAPD patients.
  • PTH levels were determined using four different assays, differentiating between mid-molecule (MM-PTH) and intact PTH (Intact PTH).
  • Ratios of PTH fragments (MM-PTH/Intact PTH and C-PTH/Intact PTH) were calculated and compared between groups.

Main Results:

  • Serum calcium and phosphorous levels were similar in both HD and CAPD groups.
  • MM-PTH levels were significantly higher in HD patients compared to CAPD patients (p < 0.001).
  • The ratio of MM-PTH/Intact PTH was higher in HD patients (p < 0.01), suggesting altered PTH metabolism or clearance.
  • In patients with similar C-PTH, CAPD patients had higher Intact PTH levels (p < 0.01).
  • The ratio C-PTH/Intact PTH was significantly higher in HD patients (p < 0.001).
  • The Peritoneal Saturation Index (PSI) of MM-PTH in CAPD patients was 23.4 +/- 12%.

Conclusions:

  • CAPD may lead to peritoneal losses of PTH fragments, potentially altering serum levels of MM-PTH and Intact PTH.
  • Differences in PTH fragment ratios between HD and CAPD suggest distinct impacts of these modalities on PTH metabolism.
  • Further research is needed to elucidate the clinical significance of these findings in managing mineral and bone disease in dialysis patients.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...